INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

June 3, 2021

Period of Report

June 1, 2021

Accession Number

0001062993-21-005352